Our choice of LeafCutter (17)and MHCNuggets (22) was based on LeafCutter’s benchmarking for differential splicing and MHCNuggets’ benchmarking involving MHC-binding prediction pan-cancer, respectively. This evidence concerns the gene HLA-C and cancer.